跳至主要内容
临床试验/IRCT20190804044429N4
IRCT20190804044429N4招募中2 期

Effects of pentoxifyliine on clinical outcomes of patients with COVID19: A randomaized double-blind clinical trial

Mazandaran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Inclusion criteria are adults over the age of 18 with a diagnosis of COVID-19 based on clinical criteria (presence of any symptoms of cough, shortness of breath, fever, and CT scan of the lung for evidence of involvement consistent with COVID-19 infection) or PCR.

排除标准

  • History of allergy to any drugs of therapeutic regimen
  • pregnancy and lactation
  • renal and hepatic disease
  • History of cerebral or ocular bleeding
  • Glomerular infiltration less than 30 ml / min
  • History of use of pentoxifylline
  • Symptoms start more than 14 days before

研究者

相似试验